Selected article for: "immunosorbent assay and neutralization assay"

Author: Liu, Wei; Fontanet, Arnaud; Zhang, Pan-He; Zhan, Lin; Xin, Zhong-Tao; Baril, Laurence; Tang, Fang; Lv, Hui; Cao, Wu-Chun
Title: Two-Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome
  • Cord-id: 4ycdd9vh
  • Document date: 2006_3_15
  • ID: 4ycdd9vh
    Snippet: In a cohort study of 56 convalescent patients with severe acute respiratory syndrome (SARS), titers of immunoglobulin G (IgG) antibodies and neutralizing antibodies (NAbs) against SARS-associated coronavirus were assessed at regular intervals (at 1, 4, 7, 10, 16, and 24 months after the onset of disease) by use of enzyme-linked immunosorbent assay and neutralization assay. IgG antibody and NAb titers were highly correlated, peaking at month 4 after the onset of disease and decreasing thereafter.
    Document: In a cohort study of 56 convalescent patients with severe acute respiratory syndrome (SARS), titers of immunoglobulin G (IgG) antibodies and neutralizing antibodies (NAbs) against SARS-associated coronavirus were assessed at regular intervals (at 1, 4, 7, 10, 16, and 24 months after the onset of disease) by use of enzyme-linked immunosorbent assay and neutralization assay. IgG antibody and NAb titers were highly correlated, peaking at month 4 after the onset of disease and decreasing thereafter. IgG antibodies remained detectable in all patients until month 16, and they became undetectable in 11.8% of patients at month 24. The finding that NAbs remained detectable throughout follow-up is reassuring in terms of protection provided against reinfection; however, NAb titers decreased markedly after month 16

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and live sars cov challenge protect: 1, 2
    • acute respiratory syndrome and long term immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long term immunity provide: 1, 2, 3, 4
    • acute respiratory syndrome and longitudinal profile: 1, 2, 3, 4